Geode Capital Management, LLC Cullinan Oncology, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,208,421 shares of CGEM stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,208,421

Previous 976,486 23.75%

Holding current value

$16.3 Million

Previous $17 Million 18.79%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$16.03 - $20.86 $3.72 Million - $4.84 Million	231,935 Added 23.75%	1,208,421 $20.2 Million
Q2 2024 Aug 09, 2024	BUY	$15.63 - $29.35 $4.68 Million - $8.78 Million	299,156 Added 44.17%	976,486 $17 Million
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $220,343 - $412,087	21,666 Added 3.3%	677,330 $11.5 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $10.23 $511,595 - $663,323	64,841 Added 10.97%	655,664 $6.68 Million
Q3 2023 Nov 13, 2023	BUY	$9.05 - $11.72 $710,216 - $919,750	78,477 Added 15.32%	590,823 $5.35 Million
Q2 2023 Aug 11, 2023	SELL	$8.8 - $13.4 $224,197 - $341,391	-25,477 Reduced 4.74%	512,346 $5.51 Million
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $196,707 - $229,684	-19,285 Reduced 3.46%	537,823 $5.5 Million
Q4 2022 Feb 13, 2023	BUY	$9.72 - $13.62 $151,515 - $212,308	15,588 Added 2.88%	557,108 $5.88 Million
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $431,737 - $563,230	36,526 Added 7.23%	541,520 $6.94 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $13.55 $456,531 - $846,238	62,453 Added 14.11%	504,994 $6.47 Million
Q1 2022 May 13, 2022	BUY	$10.47 - $16.75 $111,714 - $178,722	10,670 Added 2.47%	442,541 $4.63 Million
Q4 2021 Feb 11, 2022	BUY	$15.36 - $25.0 $163,322 - $265,825	10,633 Added 2.52%	431,871 $6.66 Million
Q3 2021 Nov 12, 2021	BUY	$22.56 - $29.68 $4.25 Million - $5.59 Million	188,316 Added 80.85%	421,238 $9.51 Million
Q2 2021 Aug 13, 2021	BUY	$24.96 - $41.25 $315,868 - $522,018	12,655 Added 5.75%	232,922 $6 Million
Q1 2021 May 12, 2021	BUY	$28.0 - $53.42 $6.17 Million - $11.8 Million	220,267 New	220,267 $9.18 Million

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cullinan Oncology, Inc. Transaction History